POST-THROMBOTIC SYNDROME
Clinical trials for POST-THROMBOTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POST-THROMBOTIC SYNDROME trials appear
Sign up with your email to follow new studies for POST-THROMBOTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old drug, new hope: colchicine may stop Post-Clot leg damage
Disease control Not yet recruitingThis study tests whether adding colchicine, an anti-inflammatory pill, to standard blood thinners can prevent long-term vein damage after a deep vein thrombosis (DVT) in the leg. About 940 adults with a first acute DVT will receive either colchicine or a placebo for six months an…
Matched conditions: POST-THROMBOTIC SYNDROME
Phase: PHASE3 • Sponsor: Azienda Sanitaria Locale ASL 6, Livorno • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Hidden danger: clots linger after catheters removed in ICU
Knowledge-focused Not yet recruitingThis study watches 300 ICU patients to see how often blood clots caused by catheters remain in the vein after the catheter is taken out. Researchers will track risk factors and whether these clots lead to serious issues like lung clots or long-term vein damage. No new treatments …
Matched conditions: POST-THROMBOTIC SYNDROME
Sponsor: Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC